Recent MS Articles
MS Clinical Trials — Value for All Patients
MS Clinical Trials–By Vernon Rowe, Doug Schell, Arlene O’Shea, Liegh Kreishel, LeAnn Cannon, Shannon Cone, John Hunter MS Clinical Trials are an extremely important part of our MS center at the RNI, one of the major MS centers in the
High Prevalence of Sleep Disorders in Multiple Sclerosis
The MS physicians at RNI have known for some time that MS patients have a higher prevalence of sleep disorders, especially sleep disordered breathing and sleep apnea, than the general population. In a poster presentation at the Sleep meetings back
Cooking and Diet in MS
Cooking and Diet in MS–Fight Aches and Pains with a Four Letter Word….FOOD! by Leigh Kreshel and Kelli Wong Effective management of a chronic disease, such as Multiple Sclerosis, can be difficult. The diet in MS is an important factor
This Is MS Awareness Month–MS Treatment
by Vernon Rowe, Doug Schell, and Aaron Seacat March is MS Awareness Month. This time of year we as a country focus on MS, a disease that affects more than 400,000 people in the US and is a major crippler
More Than An Open Low Cost MRI–A Neurologist Who Can Read It and Treat You
We believe an MRI, just like an EMG, a Sleep Study, an EEG, and nearly every other test we use, is merely an extension of the neurological history and examination. So you need an Open Low Cost MRI that is
Lemtrada – A New Multiple Sclerosis Treatment
Lemtrada-A New Multiple Sclerosis Treatment By Leigh Kreshel and Doug Schell A brand new Multiple Sclerosis Treatment is now available. The FDA just approved Lemtrada on November 14th as a multiple sclerosis treatment. Rowe Neurology Institute and some of our
RNI Researchers Attend International Multiple Sclerosis Meeting in Boston
Nearly nine thousand MS researchers from America and Europe converged on Boston a couple weeks ago for an exciting meeting of shared clinical and basic science research on Multiple Sclerosis. Dr. Vernon Rowe, Dr. Elizabeth Rowe, Dr. John Hunter, and
How is Multiple Sclerosis Diagnosed?
Multiple sclerosis (MS) is a chronic disease of the central nervous system that affects more than 2.3 million people worldwide. MS is usually diagnosed in patients between 20 and 40 years of age, more commonly in women than in men.
Hospital Facility Fees: A Patient’s $1,500 Nightmare
Robert Reed walked into a dermatologist’s office to have a couple moles checked. The bills he received included charges for an “operating room.”
KC Writers Anthology Reflects RNI Patient-Centered Philosophy
If you want to understand a book, don’t open it in the middle. We at RNI place unusual emphasis on patient histories, even more unusual in this age of numbers-driven healthcare (and numbers-driven everything else, too).